Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.07 - $10.25 $93,021 - $310,575
30,300 New
30,300 $163,000
Q3 2022

Nov 14, 2022

SELL
$14.67 - $21.7 $82,152 - $121,520
-5,600 Reduced 29.17%
13,600 $217,000
Q2 2022

Aug 15, 2022

SELL
$13.46 - $48.16 $129,216 - $462,335
-9,600 Reduced 33.33%
19,200 $285,000
Q1 2022

May 16, 2022

SELL
$34.22 - $47.24 $290,870 - $401,540
-8,500 Reduced 22.79%
28,800 $1.31 Million
Q4 2021

Feb 14, 2022

BUY
$43.29 - $58.77 $662,337 - $899,181
15,300 Added 69.55%
37,300 $1.72 Million
Q3 2021

Nov 15, 2021

BUY
$36.86 - $54.98 $810,920 - $1.21 Million
22,000 New
22,000 $1.09 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $29.3M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.